The LifeBridge Health Institutional Review Board (IRB) ensures that the rights and welfare of human subjects participating in research are adequately protected, the risks to subjects are outweighed by the potential benefits of the research, the selection of subjects is not coercive or biased, informed consent will be obtained and documented where appropriate, and there is scientific merit to the proposal.
Federal-Wide Assurance Number – FWA00003667
FWA Expiration Date is June 6, 2017
Continuing Renewal Submissions
All research studies require a continuing renewal (either annually or semiannually depending on the level of risk to the subject). Studies that have been identified as exempt do not require a continuing renewal.
Review the Continuing Renewal Submissions
NCI CIRB Submissions
The LBH IRB is a participant in the National Cancer Institute (NCI) Central Institutional Review Board (CIRB initiative. Any study that has been reviewed by the NCI CIRB may be submitted to the LBH IRB for a review.
Requirements of the NCI CIRB Submissions
Adverse Event Submissions
If any adverse events occur at a LifeBridge Health facility, it is required that the Adverse Events Form be completed at the time of the event and resubmitted when the continuing renewal is submitted.
Information on Adverse Event Submissions